BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27748813)

  • 1. Protocadherin γ A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth.
    Zhang X; Takata K; Cui W; Miyata-Takata T; Sato Y; Noujima-Harada M; Yoshino T
    Mol Med Rep; 2016 Nov; 14(5):4622-4628. PubMed ID: 27748813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
    Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
    Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
    Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
    Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
    Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic follicular lymphoma: clinicopathologic characteristics of a series of 32 cases.
    Mollejo M; Rodríguez-Pinilla MS; Montes-Moreno S; Algara P; Dogan A; Cigudosa JC; Juarez R; Flores T; Forteza J; Arribas A; Piris MA
    Am J Surg Pathol; 2009 May; 33(5):730-8. PubMed ID: 19194277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
    Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
    Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA signatures in subtypes of follicular lymphoma.
    Gebauer N; Gollub W; Stassek B; Bernard V; Rades D; Feller AC; Thorns C
    Anticancer Res; 2014 May; 34(5):2105-11. PubMed ID: 24778012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial lack of BCL2 in follicular lymphoma: An unusual immunohistochemical staining pattern explained by ongoing BCL2 mutation.
    van den Brand M; Garcia-Garcia M; Mathijssen JJ; Colomo L; Groenen PJ; Serrano S; van Krieken JH
    Pathol Res Pract; 2016 Feb; 212(2):148-50. PubMed ID: 26725534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2.
    Horn H; Kohler C; Witzig R; Kreuz M; Leich E; Klapper W; Hummel M; Loeffler M; Trümper L; Spang R; Rosenwald A; Ott G;
    Haematologica; 2018 Jul; 103(7):1182-1190. PubMed ID: 29567771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and immunohistochemical characterization of B-cell lymphoma-2-negative follicular lymphomas.
    Hoeller S; Bihl MP; Zihler D; Cogliatti S; Ponzoni M; Zettl A; Went P; Foerster A; Hirschmann P; Tzankov A; Dirnhofer S
    Hum Pathol; 2012 Mar; 43(3):405-12. PubMed ID: 21855110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.
    Howard MT; Dufresne S; Swerdlow SH; Cook JR
    Am J Clin Pathol; 2009 May; 131(5):656-62. PubMed ID: 19369624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.
    Louissaint A; Ackerman AM; Dias-Santagata D; Ferry JA; Hochberg EP; Huang MS; Iafrate AJ; Lara DO; Pinkus GS; Salaverria I; Siddiquee Z; Siebert R; Weinstein HJ; Zukerberg LR; Harris NL; Hasserjian RP
    Blood; 2012 Sep; 120(12):2395-404. PubMed ID: 22855608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic clues of BCL2-negative, faint, or controversial follicular lymphomas: a study of 103 cases.
    Maeshima AM; Taniguchi H; Furukawa H; Hattori D; Sasaki H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K
    Hum Pathol; 2023 May; 135():84-92. PubMed ID: 36702355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas.
    Morita K; Nakamine H; Nakai T; Takano M; Takeda M; Enomoto Y; Yoshii Y; Kanno M; Ohbayashi C
    J Clin Pathol; 2015 Jul; 68(7):541-6. PubMed ID: 25862812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.